Singular Genomics Systems, Inc. (OMIC)
| Market Cap | 1.69B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -46.61M |
| Shares Out | 69.74M |
| EPS (ttm) | -0.67 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 22 |
| Last Price | $24.27 |
| Previous Close | $23.16 |
| Change ($) | 1.11 |
| Change (%) | 4.79% |
| Day's Open | 23.16 |
| Day's Range | 23.16 - 24.40 |
| Day's Volume | 176,723 |
| 52-Week Range | 22.90 - 33.37 |
LA JOLLA, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (“Singular Genomics”), a company focused on delivering genomic technologies for the advancement of science and medicin...
Singular Genomics Systems, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock
LA JOLLA, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (“Singular Genomics”), a company focused on delivering genomic technologies for the advancement of science and medicine...
The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis.
Singular Genomics Systems, Inc. has filed to go public with an IPO on the NASDAQ.
About OMIC
Singular Genomics Systems is a life science technology company that is leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. We developed a unique and proprietary NGS technology, which we refer to as our Sequencing Engine. This Sequencing Engine is the foundational platform technology that forms the basis of our products in development and our core product tenets: accuracy, speed, flexibility and scale. We are currently developing two integrated solutions. The G4... [Read more...]
| Industry Medical Instruments & Supplies | IPO Date May 27, 2021 |
| CEO Andrew Spaventa | Employees 138 |
| Stock Exchange NASDAQ | Ticker Symbol OMIC |